This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Buck Institute for Research on Aging, Napa Therapeutics Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 51 
1 out of 1 Years Active: 2025
Title: The Innovations of Margaret Jackson
Introduction
Margaret Jackson is a notable inventor based in Sudbury, MA (US). She has made significant contributions to the field of science, particularly in the development of pharmaceutical compounds. Her work focuses on innovative solutions for treating various diseases and disorders.
Latest Patents
Margaret Jackson holds a patent for "Heteroaryl amide inhibitors of CD38." This patent discloses heteroaryl amide inhibitors of CD38 and outlines methods for making and using these compounds in the treatment of diseases and disorders. Her innovative approach has the potential to impact therapeutic strategies significantly.
Career Highlights
Throughout her career, Margaret has worked with reputable organizations, including Napa Therapeutics Limited and the Buck Institute for Research on Aging. These experiences have allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.
Collaborations
Margaret has collaborated with esteemed colleagues such as Robert A. Volkmann and Jotham W. Coe. These partnerships have enriched her research and expanded the scope of her innovative work.
Conclusion
Margaret Jackson's contributions to the field of pharmaceutical innovation are commendable. Her patent on CD38 inhibitors showcases her dedication to advancing medical science. Her career reflects a commitment to collaboration and innovation in addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile